companyprofile
Actions
Al-Razi Medical Co.
- Main Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close -
-
Open N/A
-
High
-
Low
-
No. of Trades
-
Avg. Trade size* N/A
-
Volume Traded
-
Value Traded (SAR)
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 31/08/2023 | 04/09/2023 | 13/09/2023 | Account Transfer | 0.39 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | ||||
|---|---|---|---|---|
| Total Assets | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) | - | - | - | - |
| Total Liabilities and Shareholders Equity | - | - | - | - |
| Statement of Income | ||||
| Total Revenue (Sales/Operating) | - | - | - | - |
| Net Profit (Loss) before Zakat and Tax | - | - | - | - |
| Zakat and Income Tax | - | - | - | - |
| Net Profit (Loss) after Zakat and Tax | - | - | - | - |
| Total Comprehensive Income | - | - | - | - |
| Profit (Loss) per Share | - | - | - | - |
| Cash Flows | ||||
| Net Cash From Operating Activities | - | - | - | - |
| Net Cash From Investing Activities | - | - | - | - |
| Net Cash From Financing Activities | - | - | - | - |
| Cash and Cash Equivalents, Beginning of the Period | - | - | - | - |
| Cash and Cash Equivalents, End of the Period | - | - | - | - |
| All Figures in | ||||
| All Currency In | ||||
| Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | ||||
|---|---|---|---|---|
| Total Assets | ||||
| Total Liabilities | ||||
| Total Shareholders Equity (After Deducting the Minority Equity) | ||||
| Total Liabilities and Shareholders Equity | ||||
| Statement of Income | ||||
| Total Revenue (Sales/Operating) | ||||
| Net Profit (Loss) before Zakat and Tax | ||||
| Zakat and Income Tax | ||||
| Net Profit (Loss) after Zakat and Tax | ||||
| Total Comprehensive Income | ||||
| Profit (Loss) per Share | ||||
| Cash Flows | ||||
| Net Cash From Operating Activities | ||||
| Net Cash From Investing Activities | ||||
| Net Cash From Financing Activities | ||||
| Cash and Cash Equivalents, Beginning of the Period | ||||
| Cash and Cash Equivalents, End of the Period | ||||
| All Figures in | ||||
| All Currency In | ||||
| Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The company operates under commercial registration number 1129000811 dated 2006/8/10 corresponding to 1427/7/15 AH The company s commercial activities as stated in its commercial registration consist of operating pharmacies under a license from the Ministry of Health with a license number of 6311403006110004 which expires on 1447/12/02 AH, and operating drug warehouses under a license from the Saudi Food and Drug Authority with a license number of 060401065 which expires on 1447/07/01 AH The company s activities as stated in its bylaws include the following purposes Buying and selling pharmaceuticals, medical supplies, herbal and cosmetic products, and all related products on a wholesale and retail basis Human health, health centers, and social work activities Transportation and storage Real estate activities Construction Information and communication Scientific and technical activities Administrative services and support services Other services activities The company carries out its activities according to the applicable regulations and after obtaining the necessary licenses from the competent authorities if any The company s current activity consists of storing, selling and marketing pharmaceuticals medical supplies cosmetic and pharmaceutical products
Company History
Alrazi Medical Company was initially established as an individual institution under the name of Alrazi Medical Pharmacy, owned by Yousef Abdullah Youssef Alorini, under Commercial Registration No. 1129000811 issued by the City of Albadaya on 10 Aug 2006, with a capital of 15000 S.R. The legal entity of Alrazi Medical Pharmacy, owned by Yousef Abdullah Yousef Alorini, was transformed into a limited liability company pursuant to the amended Articles of Association and Commercial Registry No. 1129000811 issued by the City of Albadaya on 10 Aug 2006, with a capital of 250000 S.R, divided into 10,000 cash shares of equal value. The value of each of them is 25 Saudi riyals owned by Mr. Yousef Abdullah Yousef Alorini, with a number of shares 9800 shares, and Mrs. Fawzia Sulaiman Abdullah Alsaghir, with a number of shares 200 shares. The company name was changed to become Alrazi Medical Company on 30 Jun 2021 The partners decided to amend the nominal value of the shares from 25 Saudi riyals per share to 1200 one thousand two hundred Saudi riyals per share, and to increase the company capital from 250000 Saudi riyals to 12000000 Saudi riyals divided into 10000 equal shares, fully paid, with a value of 1200 Saudi riyals per share. On 08 Feb 2021, the partners agreed to adjust the value of the company shares from 1200. per share to 10 Saudi riyals per share, and the number of shares ranges from 10000 shares to 1200000 shares of equal value, as was agreed on 08 Feb 2021, with the entry of six partners. It was renewed through Mr. Yousef Abdullah Yousef Alorini assignment of a number of his shares to them, and on 08 Aug 2021, the partners decided to transform the legal entity of the company and its branches into a closed joint stock company with its rights, obligations, employment, classifications, licenses and all Its financial, technical and administrative components, and the capital increase from 12000000 Saudi riyals divided into 1200000 shares to 15200000 riyals divided into 1520000 shares, and the value of each share is 10 Saudi riyals by issuing 320000 new shares at a value of 10 ten riyals per share, which represents 20 of the company capital, plus an issue premium of 21.72 riyals per share. It was agreed to allocate the issue premium amount of 6950400 riyals as a balance for the company to expand the activity, and it was paid by the new partners in cash, bringing the number of current partners in the company to 73 shareholders. The company was registered in the register of joint stock companies in accordance with Ministerial Resolution No. 532 issued on 20 Sep 2021, and registered under Commercial Registry No. 1129000811 issued by the City of Albadaya on 10 Aug 2006.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 15,200,000
- Issued Shares 1,520,000
- Paid Capital (SAR) 1,520,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2023-06-22
Investment limits
There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Mohammed Abdulrahman Mohammed Al-Suhaybani
Company Address:
King Abdulaziz Road - Al-Khaleej District - Al-Bada'ea - Al-Qassim - Kingdom of Saudi Arabia.
Contact Details:
Telephone:
0163329999
Fax
: 0163317777
Email
: info@alraziksa.com
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.